Clinical Trial Update: Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating lenalidomide for increasing lean body mass and muscle strength in inflammatory cancer cachexia syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Florian Strasser, MD ABHPM | Conditions: Cancer Cachexia Syndrome | Phase 1, Phase 2 | Status: COMPLETED